Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.

Study Site, Dublin

Study Site, Darlinghurst

Study Site, New Lambton

Study Site, Hellerup

Study Site, Fitzroy

Study Site, Adelaide

Study Site, Nedlands

Study Site, Arhus C

Study Site, Praha 4 - Krc

Study Site, Malmo

Study Site, Essen

Study Site, Tartu

Study Site, Heidelberg

Study Site, Oulu

Study Site, Nuremberg

Study Site, Vancouver

Study Site, Halifax

Study Site, Toronto

Study Site, Krakow

Study Site, Warsaw

Study Site, Bucharest